Skip to main content

Digital Diabetes Management Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Digital Diabetes Management Market are Care Innovations, LLC, GlucoMe, Medtronic, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Dexcom, Inc, Abbott, Insulet Corporation, Bayer AG

Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The rising demand for wearable devices is expected to contribute business opportunities for the market, states Fortune Business Insights, in a report, titled Digital Diabetes Management Market Size, Share & Industry Analysis, By Device Type (Hand Held, Wearable), By Product (Smart Glucose Meter, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Others), By End User (Hospitals, Home Healthcare, Others) and Regional Forecast, 2019-2026. The rising cases of diabetes are likely to foster healthy growth of the Digital Diabetes Management Market in the forthcoming years.

Key Development:

February 2020:  DreaMed Diabetes Ltd and DexCom Inc., signed into a partnership agreement to transfer DexCom’s continuous glucose monitoring (CGM) into DreaMed advisor. This platform will assist healthcare professionals to optimize patient-specific therapy.

 September 2019:  Medtronic and Novo Nordisk A/S signed an agreement to provide a digital solution for people with diabetes. The collaboration will develop solutions to integrate data from Novo Nordisk insulin pump and Medtronic’s continuous monitoring system.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-diabetes-management-market-103133


Digital Diabetes Management Market Growth Drivers:

The growing incidence of diabetes is expected to fuel demand for digital diabetes management, in turn aiding the market. According to the World Health Organization (WHO), an estimated 422 million people all over the globe have diabetes.

  • Introduction of Technologically Advanced Systems to Propel Market Growth
  • Extensive Distribution Network, Strong Portfolio, and Stout Brand Presence to Boost the Market
  • Rapid Shift towards Latest Technology in Developed and Emerging Countries
  • Launch of Innovative and Advanced Products is Propelling the Growth of the Market
  • Clinical Efficiency of New Products to Boost its Adoption during 2021-2028

To get to know more about the short-term and long-term impact of COVID-19 on this market,

Please Visit: https://www.fortunebusinessinsights.com/digital-diabetes-management-market-103133


Favorable Reimbursement Policies to Aid Growth in North America

Geographically, the global digital diabetes management market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is expected to lead the market owing to the growing adoption of digital platforms to monitor diabetes.

The favorable reimbursement policies and government initiatives for digital health are expected to create opportunities for the market. Europe is expected to witness substantial growth during the forecast period due to the emergence of start-ups in the region. With the increasing prevalence of diabetes in emerging countries such as India, China, it is expected to spur opportunities for the market in Asia Pacific.

Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/queries/digital-diabetes-management-market-103133


Digital Diabetes Management Market Segmentation:

By Device Type

  • Hand Held
  • Wearable

By Product

  • Smart Glucose Meter
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Others

By End User

  • Hospitals
  • Home Healthcare
  • Others

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Quick Buy – Digital Diabetes Management Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103133


The Report Lists the Leading Companies in the Digital Diabetes Management Market

  • Care Innovations, LLC
  •  GlucoMe
  •  Medtronic
  •  Novo Nordisk A/S
  •  F. Hoffmann-La Roche Ltd
  •  Dexcom, Inc.
  •  Abbott.
  •  Insulet Corporation
  • Bayer AG

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.